![]()
|
Report Date : |
01.12.2011 |
IDENTIFICATION DETAILS
|
Name : |
ALCO PHARMA LIMITED |
|
|
|
|
Registered Office : |
Plot No. 3/B, Plot No. 33, Section-7, Mirpur, Dhaka-1216 |
|
|
|
|
Country : |
Bangladesh |
|
|
|
|
Date of Incorporation : |
12.06.1990 |
|
|
|
|
Com. Reg. No.: |
C-7910 |
|
|
|
|
Legal Form : |
Private Limited |
|
|
|
|
Line of Business : |
Manufacturing, Selling & Exporting of Pharmaceutical
products |
|
|
|
|
No. of Employees : |
1,200 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 26,000.00 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Bangladesh |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Name Given |
Alco Pharma Ltd |
|
Address Given |
Plot No.
33 Holding No. 3/B Section 7 Mirpur, 1216 Dhaka, Bangladesh |
|
Tel No Given |
NIL |
|
Fax No Given |
NIL |
|
E-Mail Given: |
NIL |
|
Name |
Alco Pharma
Limited |
|
Address |
Plot No.
3/B, Plot No. 33, Section-7, Mirpur, Dhaka-1216 |
|
Country |
Bangladesh |
|
Telephone No |
880-2-8826103 |
|
Fax No |
880-2-8814900 |
|
E-Mail |
|
|
Website |
www.alcopharma.com |
|
Established |
1990 |
|
Company Registration No |
C-7910 |
|
Registration date |
12th
June 1990 |
|
Legal Status |
Private Limited |
|
Issuing Authority |
The
Registrar of Joint Stock Companies & Firms, Dhaka |
|
Business Type |
Manufacturing,
Exporting & Selling |
|
Status |
Satisfactory |
|
Payment Behavior |
No complaints have been heard regarding payments from
local suppliers or banks. |
|
Head Office |
House No.21, Road
No.113/A Gulshan-2, Dhaka-1212 |
|
Telephone No |
880-2-8826103 |
|
Fax No |
880-2-8814900 |
|
E-Mail |
|
|
Website |
www.alcopharma.com |
|
Branch |
NIL |
|
Factory |
Plot No. 3/B,
Plot No. 33, Section-7, Mirpur, Dhaka-1216 |
|
Factory Telephone No |
NIL |
|
Factory Fax No |
NIL |
|
Warehouse |
Plot No. 3/B,
Plot No. 33, Section-7, Mirpur, Dhaka-1216 |
|
Name |
Mr. Wahidur
Rahman |
|
Designation |
Chairman &
Managing Director |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. M.A. Salam |
|
Designation |
Director |
|
Nationality |
Bangladeshi |
|
Name |
Mr. Wahidur
Rahman |
|
Share Percent |
70% |
|
Nationality |
Bangladeshi |
|
|
|
|
Name |
Mr. M.A. Salam |
|
Share Percent |
30% |
|
Nationality |
Bangladeshi |
|
Line of Business |
Manufacturing,
Selling & Exporting |
|
Items Dealing In |
Pharmaceutical
products |
|
Terms of Purchase |
Local: Cash or Credit Import: Against L/C |
|
Terms of
Purchase |
Local: Cash or Credit Export: Against L/C |
|
Name |
IFIC Bank Ltd |
|
Branch |
Gulshan Branch |
|
Address |
Gulshan, Dhaka |
|
SWIFT |
N/A |
|
Year |
2010 |
2009 |
2008 |
|
Investment |
Tk.52 million |
Tk.50 million |
Tk.50 million |
|
Turnover |
Tk.411.4million |
Tk.410.6 million |
Tk.410 million |
|
Liability |
NIL |
NIL |
NIL |
|
Assets |
Tk.70 million |
Tk.68 million |
Tk.68 million |
|
Authorized
Capital |
Tk.20 million |
|
Paid Up Capital |
Tk.250,000.00 |
|
Each Share Value |
Tk.100.00 |
|
Currency |
Unit |
Bangladeshi Taka (BDT) |
|
Great Britain Pound |
1 |
120.0640 |
|
U.S Dollar |
1 |
76.9000 |
|
European Euro |
1 |
102.5231 |
|
Dishonored
Checks |
No Found |
|
Debt |
No Records Found |
|
Litigation |
No Records Found |
|
Performance
Defaults |
No Records Found |
|
Adverse Press
Coverage |
No Records Found |
|
Money Laundering |
No Records Found |
|
Amount |
Based On |
|
US$ 26,000.00 |
90 days |
|
Employees |
1,200 |
|
Office Area (Sq.
Ft) |
2,000 sq.ft (rented) |
|
Factory Area
(Sq. Ft) |
40,000 sq.ft (owned) |
|
Warehouse Area
(Sq. Ft) |
7,200 sq.ft (owned) |
|
Range of
Products |
4 Penicillin 4 Cephalosporin 4 Fluroquinolones 4 Oxazolidinone 4 Sulfonamides 4 Macrolide |
|
Major
Clients |
4 Local
Medical 4 Local
Specialized Hospitals 4 Local
Consumer |
|
Export Market |
4 Asian Countries 4 African Countries |
|
Certifications |
4 ISO 9001:2000 |
|
Group Name |
NIL |
|
Subsidiaries /
Affiliates |
NIL |
|
Member |
4 Bangladesh Association of
Pharmaceutical Industries, Dhaka 4 Dhaka Chamber of Commerce &
Industries, Dhaka |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.52.16 |
|
|
1 |
Rs.81.29 |
|
Euro |
1 |
Rs.69.47 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.